Catalyst Pharmaceuticals, Inc.
CPRX
株式のランク
#4168
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables,... Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an amifampridine phosphate tablet formulation approved for managing Lambert-Eaton Myasthenic Syndrome (LEMS). Catalyst also provides Ruzurgi, a specific treatment option for pediatric patients diagnosed with LEMS. Beyond its existing products, Catalyst is actively investigating additional applications for Firdapse, including its potential use in treating MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and hereditary neuropathy with liability to pressure palsies. The company engages in various strategic collaborations, such as licensing agreements with BioMarin Pharmaceutical Inc., and a joint development and commercialization agreement with Endo Ventures Limited concerning a generic version of Sabril tablets. Previously known as Catalyst Pharmaceutical Partners, Inc., the company adopted its current name in May 2015.
株価
$31.49
最終同期: 2026-07-21
時価総額
$3.85B
変化（1日）
0.00%
変化（1年）
49.88%
国
US
取引 Catalyst Pharmaceuticals, Inc. (CPRX)
カテゴリー
Healthcare
Catalyst Pharmaceuticals, Inc.（CPRX）のP/S比率
October 2026 時点のP/S比率 TTM: 6.46
Catalyst Pharmaceuticals, Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 6.46 です。2023 年末時点でのP/S比率は 4.49 でした。
Catalyst Pharmaceuticals, Inc. の P/S 比率の履歴（2002 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 6.46 | 28.38% |
| 2024 | 5.03 | 12.06% |
| 2023 | 4.49 | -50.02% |
| 2022 | 8.98 | 80.63% |
| 2021 | 4.97 | 71.16% |
| 2020 | 2.90 | -23.05% |
| 2019 | 3.77 | -99.04% |
| 2018 | 394.11 | 0.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | 0.00% |
| 2012 | 0.00 | 0.00% |
| 2011 | 0.00 | -100.00% |
| 2010 | 37.62 | 0.00% |
| 2009 | 0.00 | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| 10.02 | 55.20% |
US
|
|
| 40.55 | 527.95% |
US
|
|
| 3.96 | -38.66% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | 57.12% |
NL
|
